Babson Diagnostics, an Austin, Texas-based medical technology company, closed $13.7m in cumulative Series A funding.
Data Gumbo, a Houston, TX-based industrial blockchain network, held the first close in its Series B funding round of $4m.
Sunrise Capital, a Japan-dedicated mid-cap private equity fund, closed Sunrise Capital IV, at US$450m of commitments.
Samsung Biologics is a fully integrated CDMO that offers one-stop services in development, manufacturing and biosafety testing. With the largest single-site capacity, Samsung Biologics is an award-winning company that has continued to operate with success despite the COVID-19 pandemic.
Summary Pandemic shown how lack of digitalization in public services impacted real estate market: 5x crowdlending volume difference we’ve discovered between Spain and Estonia. Market is already recovered in terms of crowdlending volumes in Baltics, even with the restrictions still in place. Case from EvoEstate’s customer with 130% XIRR confirmed that every crisis provides opportunities […]
ImmVira Group Company, a Chinese biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics, signed US$10m Series B Plus strategic financing.
Leaf, a San Francisco, CA-based food and agriculture’s data infrastructure company, raised $2m in seed funding.
Uncapped, a London, UK-based growth finance company for online brands to fund marketing and inventory, raised $26m in debt and equity funding.
Spiceology, Inc., a Spokane, Wash.-based spice company, closed a $4.7m round of financing.
Violux, an Irvine, Calif-based creator of smart Ultraviolet (UV) light cleaning technology, raised $1.2m in seed funding round.
daring, a Los Angeles, CA-based clean plant-based chicken company, closed an $8m Series A funding.
Salsify, Inc., a Boston, MA-based commerce experience platform for brands to win on the digital shelf, closed a $155m Series E round of financing.
ShoppingGives, a Chicago, IL-based Social Impact Commerce platform that offers turn-key social impact and donation processing for retailers, raised $5.5M in seed funding.
Silverback Therapeutics, Inc., a Seattle, WA-based clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered and tissue-targeted therapeutics for the treatment of cancer and other serious diseases, closed an $85m Series C financing.
Bright Health Inc., a Minneapolis, MI-based health plan company, raised $500M in Series E funding.